On April 21, 2025, Kura Oncology joined the acute myeloid leukemia (AML) patient, advocacy and medical community in celebrating AML World Awareness Day.
AML is a type of blood cancer that starts in the bone marrow, and impacts the development of red blood cells, white blood cells, and platelets. As the most common form of leukemia in adults, there are about 120,000 new cases of AML per year globally.
Kura Oncology remains committed to the AML community, working as one for patients in developing potential new treatments for AML.
To learn more about our commitment to AML patients from early research to advocacy partnerships, watch the full video here.
